Magnesium as a Calcification Inhibitor.

Adv Chronic Kidney Dis

INSERM U1088, CURS, Amiens, France; Division of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt/Paris, France; INSERM U1018, Team 5, CESP, UVSQ, Villejuif, France. Electronic address:

Published: May 2018

Vascular calcification (VC) is associated with elevated cardiovascular mortality rates in patients with CKD. Recent clinical studies of patients with advanced CKD have observed an association between low serum magnesium (Mg) levels on one hand and elevated VC and cardiovascular mortality on the other. These findings have stimulated interest in understanding Mg's impact on CKD in general and the associated VC in particular. In vitro and preclinical in vivo data indicate that Mg has the potential to protect vascular smooth muscle cells against calcification via several different molecular mechanisms. Accordingly, data from pilot interventional studies in the clinic suggest that oral Mg supplementation reduces VC in patients with CKD. The present review provides an overview of our current understanding of the impact of Mg on the development of VC in patients with CKD.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ackd.2017.12.001DOI Listing

Publication Analysis

Top Keywords

patients ckd
12
elevated cardiovascular
8
cardiovascular mortality
8
ckd
5
magnesium calcification
4
calcification inhibitor
4
inhibitor vascular
4
vascular calcification
4
calcification associated
4
associated elevated
4

Similar Publications

Background: A bladder outlet procedure (BOP) without augmentation cystoplasty (AC) for incontinence from neurogenic bladder has risks including renal damage and future surgeries.

Objective: Our objective was to obtain long-term outcomes after BOP without AC and identify risk factors for adverse outcomes. We hypothesized that high preoperative bladder compliance is associated with lower risk of subsequent AC or diversion (AC/D) and dimercaptosuccinic acid renal scan (DMSA) abnormalities.

View Article and Find Full Text PDF

Objectives: Prior studies have demonstrated that frailty, characterized by a patient's burden of chronic medical comorbidities, is predictive of adverse outcomes across surgical specialties. This study utilizes the clinical frailty score (CFS) to assess the impact of phenotypic frailty on long-term mortality and return to preoperative functional status following fenestrated and branched endovascular repair (F/BEVAR) for thoracoabdominal aortic aneurysm (TAAA).

Methods: All patients enrolled in a prospective, physician-sponsored IDE clinical trial from 2012 to 2023 following F/BEVAR for TAAA were included.

View Article and Find Full Text PDF

Social disconnection, psychometric pain risk prediction, and cardiovascular disease with life expectancy in patients with chronic kidney disease.

J Affect Disord

March 2025

Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China; Liaoning Key Laboratory of Precision Medical Research on Major Chronic Disease, Shenyang, Liaoning Province, China. Electronic address:

Background: Understanding the impact of psychosocial factors and pain management on cardiovascular disease (CVD) risk and life expectancy in patients with chronic kidney disease (CKD) is critical for developing targeted interventions. We aimed to assess the associations of social isolation, loneliness, and pain risk with incident CVD in patients with CKD and to evaluate the impact of these factors on the life expectancy of CKD patients.

Methods: This prospective cohort study comprised 334,381 CKD patients from the UK Biobank.

View Article and Find Full Text PDF

The progressive degradation of the renal parenchyma and reduction of functional nephrons characterise chronic kidney disease (CKD). Disorders of bone mineral metabolism is one of the leading causes of morbidity and mortality in CKD. Calcium-sensing receptor (CASR) allows cells to detect changes in blood calcium levels and regulate its concentration.

View Article and Find Full Text PDF

Obesity and Metabolic Health in CKD.

Clin J Am Soc Nephrol

March 2025

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.

Obesity is a worldwide epidemic with a future projected growth of 40% over ten years. Obesity increases the risk of diabetes, hypertension and cardiovascular disease, and it also leads to higher risk of chronic kidney disease, both through direct and indirect mechanisms. While obesity is a feature of over-nutrition and is associated with poor outcomes in the general population, obese individuals with chronic kidney disease often display complex metabolic patterns such as sarcopenic obesity, and obesity can be associated with better survival in individuals with advanced chronic kidney disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!